U.S. appeals court invalidates four Merck Cubicin patents
November 12, 2015 at 13:03 PM EST
Nov 12 (Reuters) - Drugmaker Merck & Co Inc said the U.S. Court of Appeals for the Federal Circuit invalidated four patents related to the antibiotic, Cubicin, that expire in 2019 and 2020.
